By Tucker Reals, Steve Berriman
April 19, 2021 / 7:02 AM / CBS News New study may shed light on COVID blood clots
London A study by researchers at Oxford University in England suggests the risks of experiencing dangerous, rare blood clots in the brain are far higher in those who catch the coronavirus than in those who get either the AstraZeneca vaccine, or the vaccines made by Pfizer and Moderna in the U.S.
Another finding of the research, which was disputed by Pfizer and called confusing by the top infectious disease expert in the U.S., was that the number of people who experience clots after getting the vaccines made by the American companies appears very similar to the number who get the rare condition after a shot of the AstraZeneca drug, which was developed in conjunction with Oxford s vaccine institute.
AstraZeneca about investigating the clots and to “speak with one voice about safety.” However, both Pfizer and Modera declined, indicating that their vaccines were not associated with blood clots.
The two companies didn’t see a need to duplicate regulators investigations, and they are already studying the blood clotting. Some of the sources said there were concerns Pfizer and Moderna might be linked to the blood clotting issue.
So far, both the AstraZeneca-Oxford and Johnson & Johnson COVID-19 vaccines have been
associated with very rare but potentially life-threatening blood clots. The actual cause of the clotting has not been determined.
In addition, the blood associated with each vaccine appears to be different from the other. The U.S. has paused the distribution of the J&J vaccine. The AstraZeneca-Oxford vaccine has been halted in about 20 European countries but has yet to be authorized in the U.S.
LONDON (April 15): People infected with Covid-19 are at a higher risk of developing the rare blood clotting known as cerebral venous thrombosis (CVT) than those who get a vaccine against the disease, a study published on Thursday by the University of Oxford, where the AstraZeneca vaccine was developed, said. According to the findings, in the 500,000 virus patients studied, 39 in a million suffered from blood clots, with 30% of cases found in those under the age of 30, while around five in a million cases were reported in patients who had had a first dose of the AstraZeneca/Oxford vaccine.
France Covid-19 death toll surpasses 100,000
From CNN’s Saskya Vandoorne
France marked a grim milestone Thursday as its Covid-19 death toll exceeded 100,000, according to the French health ministry’s Geodes website.
France has registered 100,077 total deaths, and currently has the eighth highest global death toll, according to data from Johns Hopkins University.
share with Facebook
Fauci: UK study on blood clots, vaccines and Covid-19, has some procedural gaps
From CNN s Jacqueline Howard Susan Walsh/AP
There remains some confusion around new research from the University of Oxford in the United Kingdom that compares the risk of a rare type of blood clot among people who have had Covid-19 with people who received the AstraZeneca, Moderna and Pfizer vaccines, Dr. Anthony Fauci said.
COVID-19 leads to 100 times greater blood clotting risk than COVID-19 vaccination: Oxford Study medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.